Catalysts

PRODUCTS

  • GettyImages-1394004470 ovarian cancer
    Oncology Consulting Solutions

    Access specialized data and expertise to help navigate all stages of product development and support your success in oncology.

  • GettyImages-1074166486-brain-scan-results-radiologist-doctor
    PACS: Imaging Platform for Researchers

    Access, interact with, and even adjudicate clinical trial imaging from the same platform where you manage all other study data.

  • Isolated Antibody Drug Conjugates ADCs GettyImages-1438509824
    Antibody-Drug Conjugates

    Antibody drug conjugates (ADCs) are the emerging class of anti-cancer therapeutic drugs. ADCs combine an antibody capable of recognizing cancer cells and cytotoxic small-molecule drugs via cleavable or non-cleavable linkers, thereby transforming the 3-unit combination into a targeted therapeutic drug for cancer treatment. In recent years, ADCs have rapidly developed and there are not only more than 14 approved drugs on the market but also many investigational drugs undergoing clinical trials. Furthermore, ADCs have shown potential for treating various diseases beyond cancer, such as Autoimmune disorders, Infectious diseases, Inflammatory conditions and so on.  

  • Hull i-Dositecno
    Pharmaceutical Labeling Equipment For Injectable Products

    Ensuring you have equipment that accurately and rapidly assembles syringes and cartridges is crucial to the success of your pharmaceutical manufacturing workflow. The Hull i-Dositecno SY pharmaceutical labeling machine harnesses dual-function robotics for plunger insertion and labeling to ensure the safety and sterility of your product.

    • Versatile – ideal for syringes or cartridges in sterile, clean, ready-to-fill (SCF) tubs
    • Cleanroom ready
    • Fully compliant – 21 CFR Part 11 software and IQ/OQ validation packages available
  • singota labeling solution
    Pharmaceutical Labeling And Kitting Services

    Discover agile labeling and packaging services for pharmaceuticals, specializing in custom designs, regulatory support, and small to medium batch production with quick turnaround times.

WHITE PAPERS AND CASE STUDIES

NEWS

ABOUT

 

Catalysts

Catalysts work by changing the structure of a molecule or by bonding to reactant molecules causing them to combine, react, and release a product or energy.  For example, a catalyst is required in order for oxygen and hydrogen to bond, combine and produce water.

Catalysts increase the rate of chemical reactions. Unlike a reagent that gets consumed as apart of the chemical reaction, catalysts do not get consumed in the reaction. They can actually participate in multiple chemical transformations.Catalysts can be organic, synthetic or metal.

All processes need energy to take place. Processes require a very high level of energy in order to spark or start if a catalyst isn’t present.  When a catalyst is present the amount of energy required to spark the reaction is lowered and that makes the reaction happen faster and more efficiently.

Catalytic effects vary depending on other substances present that are a part of the chemical reactions. There are certain substances that can inhibit the effectiveness of a catalyst like poisons, and other substances that promote or increase the effect of the catalyst.  Inhibitors or negative catalysts are very important in medicine to treat mental illnesses, high blood pressure, cancer and many other diseases.

Catalysts are often used to help crack, or split, larger organic molecules like hydrocarbons into simpler molecules. It does this by breaking carbon-carbon bonds. The speed of the splitting process depends heavily on what specific catalyst is used and the temperature.  Applications of this technology include oil and petrochemical industries.